🇺🇸 FDA
Patent

US 10160954

Engineered physical alignment of stem cell-derived cardiomyocytes

granted A61PA61P9/04

Quick answer

US patent 10160954 (Engineered physical alignment of stem cell-derived cardiomyocytes) held by The Regents of the University of California expires Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P9/04